Advances in Nanocarriers for Delivering Therapeutic Agents Against Hepatitis B Virus

Hepatitis B virus (HBV) infection is a crucial public health issue and a major cause of liver disease, such as cirrhosis and hepatocellular carcinoma. At present, orally administered small molecule drugs, such as nucleoside / nucleotide analogues, are recommended as the first‐line treatment for HBV....

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Advanced NanoBiomed Research
المؤلفون الرئيسيون:	Jia Li, Jianlan Yuan, Hugang Li, Jingyi Guo, Mingjun Li, Tingbin Zhang, Xing‐Jie Liang, Haiming Fan, Xiaoli Liu
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley-VCH 2024-06-01
الموضوعات:	drug delivery hepatitis B virus infection hepatitis B virus nanotherapeutics nanocarriers
الوصول للمادة أونلاين:	https://doi.org/10.1002/anbr.202300132